← All candidates
One insider buy in the last year — $235.8K in all.
4 filings on record.
SPTXSeaport Therapeutics, Inc.
NasdaqGS · Healthcare · $1.25B
$23.34
+0.26% · Sep 11
One insider buy in the last year — $235.8K in all.
Nothing in the last fortnight.
Price · 1Y · daily● 1 buy
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 2 moves explained
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$1.25B
Float
18.4M
34% public
Short % float
Pro
The buyers
▸ each insider's past open-market buys, measured ~6 months (120 trading days) later, against the S&P over the same spans · split-adjusted · pre-scheduled 10b5-1 plan trades excluded · past outcomes, not predictions
Director
Hombach Robert J.
Bought $235.8K on Jun 22 — 13,000 sh @ $18.14, held indirect, 100% of their stake.
No completed positions to measure
Institutional stakes
▸ a holder crossing 5% files Schedule 13D if they intend to act on the company, 13G if they certify they will not · /A amends an earlier filing
3 filingsnewest first
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
Context
Wall St
$38.00 avg target
+62.8% vs today · 5 analysts · consensus Strong Buy
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
0 of 2 quarters beat
Q2 '26−$1.78 act−$1.12
Q1 '26−$10.34 act−$6.46
The file stays open
4 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice